Chronic Effects of Neurotrauma Consortium (CENC) Imaging Core

神经创伤联盟 (CENC) 影像核心的慢性影响

基本信息

项目摘要

Project Background/Rationale: The mission of the Chronic Effects of Neurotrauma Consortium (CENC) is to fill gaps in knowledge about the basic science of concussion or mild traumatic brain injury (mTBI), determine its effects on late-life outcomes and neurodegeneration, identify Service Members most susceptible to these effects, and identify the most effective treatment strategies. The CENC is a multi-center collaboration linking premier basic science, translational, and clinical neuroscience researchers from the Department of Defense, VA, academic universities, and private research institutes to effectively address the scientific, diagnostic, and therapeutic ramifications of mTBI and its long-term effects. The Houston-based CENC Neuroimaging Core is comprised of an interdisciplinary team of neuroimaging experts from neuroradiology, neuropsychology, MR physics, information technology and computer programming, and statistics who facilitate sequence development and pulse programming, training and supervision of technologists, acquisition of imaging data, quality assurance, conventional and advanced imaging analysis, transfer and storage of imaging data, and assistance in interpreating neuroimaging data for existing and future Consortium projects. The Core is comprised of both VA- and academic-affiliate resources; an expansion of existing Core funds already granted to the academic affiliate (Baylor College of Medicine) is needed due to the Consortium's growth and the resulting change in the Core's scope of work. Specifically, expansion of the number of study sites for existing studies and the addition of several new projects has substantially increased the Core's responsibilities, including additional oversight, quality control, analysis, and administrative duties for Michael E. DeBakey VA Medical Center (MEDVAMC)-based Core investigators and staff. Project Objectives: Objectives of the Neuroimaging Core are to: 1) assist in the acquisition of brain imaging data, including conventional magnetic resonance imaging (MRI), detailed volumetry and cortical thickness, diffusion tensor imaging (DTI), arterial spin labeling (ASL), and resting state functional connectivity MRI (fcMRI); 2) transfer, convert, analyze, and store brain imaging data; 3) direct and assist in performing quality assurance of the scanners at all sites involved in imaging data collection; and 4) communicate with the investigators of projects involving imaging to facilitate integration of imaging data into the projects to address their aims. Project Methods: The collective expertise of the investigators in the Core facilitates utilization and analysis of several conventional and advanced imaging techniques. MEDVAMC-based Core personnel, including MR physicists, oversee quality assurance testing on each magnet, which is performed on a regular basis to ensure scanner accuracy, stability, and comparability. Core personnel assist in the pulse programming and sequence development for advanced MR sequences used in specific projects. Core investigators provide additional training to MR technologists and also to project coordinators on preparing participants to undergo imaging. Core personnel additionally provide assistance with computer programming to facilitate data sorting and analysis. Due to the complex nature of transferring and storing very large amounts of data as well as frequent software updates required by some imaging analysis programs, individuals with IT expertise are also involved. Core personnel also train and supervise all image analysts, assist in the interpretation of imaging data, and assist in manuscript preparation.
项目背景/基本原理:神经创伤慢性效应联盟(CENC)的使命是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elisabeth A Wilde其他文献

Elisabeth A Wilde的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elisabeth A Wilde', 18)}}的其他基金

VA-DoD Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC): Neuroimaging Core
VA-DoD 军事相关脑损伤联盟 (LIMBIC) 的长期影响:神经影像核心
  • 批准号:
    10001813
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
CENC - Diffusion Tensor Imaging Standardization using Novel MR Diffusion Phantoms
CENC - 使用新型 MR 扩散模型进行扩散张量成像标准化
  • 批准号:
    10098003
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Chronic Effects of Neurotrauma Consortium (CENC) Imaging Core
神经创伤联盟 (CENC) 影像核心的慢性影响
  • 批准号:
    9126783
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Chronic Effects of Neurotrauma Consortium (CENC) Imaging Core
神经创伤联盟 (CENC) 影像核心的慢性影响
  • 批准号:
    9812778
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
CENC - Diffusion Tensor Imaging Standardization using Novel MR Diffusion Phantoms
CENC - 使用新型 MR 扩散模型进行扩散张量成像标准化
  • 批准号:
    9032373
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了